Clinical Trials Logo
  1. Home
  2. Pregnancy
  3. NCT02414919
  4. Details
NCT02414919 Clinical Trial

Duration of Use of Highly Effective Reversible Contraception

Pregnancy Clinical Trial

Official title:
Real-world Duration of Use for Highly Effective Reversible Contraception (HERC): A Retrospective Review

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT02414919
Other study ID # 17714
Secondary ID
Status Completed
Phase N/A
First received April 8, 2015
Last updated March 14, 2017
Start date April 1, 2015
Est. completion date March 28, 2016

Study information
Verified date March 2017
Source Bayer
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To assess the proportion of women who use HERC for ≥2 years of duration

Recruitment information / eligibility
Status Completed
Enrollment 13880
Est. completion date March 28, 2016
Est. primary completion date March 28, 2016
Accepts healthy volunteers No
Gender Female
Age group 15 Years to 44 Years
Eligibility Inclusion Criteria:

-Women who had an IUD or contraceptive implant inserted and removed within the University of Utah from January 1, 2004 to October 31, 2012

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Mirena (Levonorgestrel IUS, BAY86-5028)
Levonorgestrel-releasing intrauterine device 20 mcg/day
• ParaGard
Copper T380A
• Implanon/Nexplanon
Etonorgestrel contraceptive implant

Locations
Country Name City State
n/a

Sponsors (2)
Lead Sponsor Collaborator
Bayer University of Utah

Country where clinical trial is conducted

United States, 

References & Publications (3)

Sanders J, Turok D, Gawron L, Law A, Wen L, Lynen R. Continuation of Long-Acting Reversible Contraception at Two Years in a University Healthcare Setting: A Retrospective Review. JMCP 2016;22(4a):S126

Sanders J, Turok D, Gawron L, Law A, Wen L, Lynen R. Three-Year Continuation of Long-Acting Reversible Contraceptive methods in a Mixed-Payer Health Care Setting: A Retrospective Review. Contraception 2016;94:405-406.

Sanders JN, Turok DK, Gawron LM, Law A, Wen L, Lynen R. Two-year continuation of intrauterine devices and contraceptive implants in a mixed-payer setting: A retrospective review. Am J Obstet Gynecol. 2017 Feb 8. pii: S0002-9378(17)30180-1. doi: 10.1016/j. — View Citation

Outcome
Type Measure Description Time frame Safety issue
Other Difference in patient characteristics of women who chose different HERC devices 2 years post-HERC initiation
Other Proportion of HERC used for =3 years of duration =3 years post-HERC initiation
Other Model the predictors of =3 years of duration =3 years post-HERC initiation
Primary Proportion of women who use HERC 2 years post-HERC initiation
Secondary Duration of real world use of three different HERC devices 2 years post-HERC initiation
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Completed NCT02408315 - Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE) Phase 3

External Links